Ikena Oncology, Inc.IKNANASDAQ
Loading
Operating Expenses Over TimeStable
Percentile Rank57
3Y CAGR-16.5%
5Y CAGR+40.9%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-16.5%/yr
vs +19.5%/yr prior
5Y CAGR
+40.9%/yr
Recent deceleration
Acceleration
-35.9pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
5.6x
Strong expansion
Streak
3 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $49.25M | -8.9% |
| 2024 | $54.06M | -35.3% |
| 2023 | $83.56M | -1.1% |
| 2022 | $84.49M | +369.0% |
| 2021 | $18.02M | +103.2% |
| 2020 | $8.87M | -72.5% |
| 2019 | $32.24M | -22.2% |
| 2018 | $41.46M | - |